Thymidylate Synthase is an Independent Predictor of Prognosis in Chinese Gastric Cancer Patients aft

来源 :第十三届全国胃癌学术会议 | 被引量 : 0次 | 上传用户:lyl_chong
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective The study was designed to assay the expression of Thymidylate Synthase(TS)on freshly-removed gastric cancer tissues and analyze its significance in predicting the prognosis.
其他文献
Objective To compare the short-term surgical outcomes,including financial cost and surgeons acceptance,of robotic versus three-dimensional high-definition(3D HD)laparoscopic gastrectomy for patients w
Objective Aim Gastric cancer(GC)is a common tumor-associated lethal disease,and invasiveness and metastasis are primary challenges in its clinical treatment.
Objective Previous studies have shown that FOXO3,a member of the forkhead box O(FOXO)family,regulates autophagy in various cells.To date,whether the induction of autophagy in gastric cancer(GC)cells i
Objective 1.To explore new molecular mechanism in driving 5-FU sensitivity of colorectal cancer to fulfill unmet clinical need.
目的 探讨缺氧诱导因子-1α(HIF-1α)与P-gp 在胃癌组织中的表达情况及其与患者预后的关系.方法 采用免疫组化染色法检测120 例胃癌根治术切除的胃癌组织和50 例正常胃黏膜组织中的HIF-1α 和P-gp.
Objective Gastric cancer is one of the most common malignancies worldwide.The treatment options are limited and research to elucidate the molecular mechanisms underlying this disease is needed to look
目的 探索在肿瘤相关成纤维细胞(CAF)和MET 非扩增胃癌细胞之间由HGF 介导的调控网络,并研究其对肿瘤生长及转移的调控作用。方法 研究CAF 分泌的HGF 对MET 阴性、MET 扩增、MET 非扩增胃癌细胞系的生物学功能影响。探究HGF 对MET 非扩增胃癌细胞系的生物学功能影响的分子机制。
目的 探索肿瘤相关成纤维分泌的HGF 在胃癌中对血管化的作用及其潜在机制。方法 采用ELISA 、qRT-PCR 和western blots 分析胃癌细胞系、人脐静脉内皮细胞(HUVEC)及肿瘤相关成纤维细胞中HGF 和c-Met 的表达。采用CCK-8 试剂及建立共培养体系分别检测肿瘤相关成纤维细胞分泌的HGF 对HUVECs 及胃癌细胞增殖和迁移的影响。
Objective The purpose of this study is to illustrate the key role and biological mechanisms of HER4-YAP1 axis promoting trastuzumab resistance in HER2-positive gastric cancer cells by inducing epithel
Objective Gastric cancer is one of the most common malignancy and the third dominant cause of cancer death worldwide.The prognosis of GC is very poor and the five-year survival is less than 30%.